Celldex Therapeutics Inc (CLDX)
Operating Income Growth
-26.26%
Quarterly · Period ending:
CLDX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.26%period ending
Latest reported-26.26%period ending
CLDX Quarterly Operating Income YoY % (500.00% → -26.26%)
Year-over-year change
High-resolution chart · PNG
CLDX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -105.994% | |
| -61.4081% | |
| -32.4189% | |
| -60.2444% | |
| -29.913% | |
| 3.2267% | |
| -57.772% | |
| -17.3913% | |
| -43.75% | |
| -100% | |
| -47.0588% | |
| -9.5238% | |
| 15.7895% | |
| 25% | |
| 37.037% | |
| 8.6957% | |
| 56.8182% | |
| 16.6667% | |
| 15.625% | |
| 30.303% | |
| -69.2308% | |
| 11.1111% | |
| -52.381% | |
| -32% | |
| 0% | |
| -17.3913% | |
| 8.6957% | |
| 7.4074% | |
| -44.4444% | |
| -15% | |
| -92.8571% | |
| -20% | |
| -5.2632% | |
| 33.3333% | |
| 11.7647% | |
| -46.1538% | |
| 20% | |
| -110% | |
| -41.6667% | |
| -1,400% | |
| -400% | |
| -141.6667% | |
| -157.1429% | |
| 101.4085% | |
| -110.5263% | |
| 26.3158% | |
| 23.5294% | |
| -22.4138% | |
| 26.6667% | |
| 58.3333% | |
| 70% | |
| -61.1111% | |
| 87.5% | |
| 100% | |
| 400% | |
| -80% | |
| 700% | |
| 500% |